International Cannabis Weekly: 139

• How the coronavirus is impacting cannabis consumer behaviour.
• The Netherlands reports cannabis bulk-buying as residents prepare for lockdown.
• Cannabis users should avoid sharing joints due to coronavirus health concerns.
• San Francisco reverses dispensary closure decision to protect patient access.
• Cannabis dispensaries are seeing a surge in home deliveries amid outbreak.

• US advocacy group asks governors to protect medical cannabis access amid shutdowns.
• Dutch cannabis coffeeshops told to remain open despite national lockdown measures.
• Canopy Growth temporarily closes all of its physical retail outlets in Canada.

• Switzerland authorises cultivation of medical cannabis for domestic use and export.
• Britain’s largest private cannabis clinic network pivots to online video consultations.
• New German cannabis association set up to ensure quality assurance.
• Irish campaigner pleads to maintain access for medical cannabis patients.

• Florida’s Surgeon General opens digital consultations for medical cannabis patients.
• Netflix to debut a six-episode cannabis-based cookery competition on April 20.
• Total medical cannabis sales in Arkansas surpass US$50 million.
• Female leaders in the US cannabis space speak on equality and inclusion in the industry.

• Australia’s MediPharm Labs signs supply agreement with Compass Clinics Australia.
• ECS Botanics granted special industrial hemp licence by the Tasmanian government.
• Western Australia begins in-state hemp seed production.

• Mexican hemp stakeholders criticise proposed cannabis law as too restrictive on hemp.
• Bolivian lawmakers are investigating legalising cannabis for medical purposes.
• Colombian officials ask companies to adequately fill their cannabis cultivation quotas.

• Israel welcomes its first medical cannabis imports from the United States.
• Cannabis Expo Cape Town 2020 postponed indefinitely.
• South African advocates ask employers to rethink zero-tolerance cannabis policies.

• AOAC International calls for submission of unique cannabis-edible testing methods.

• Key insights from PSYCH: The Psychedelics as Medicine Report.
• Hawaiian lawmakers introduce legislation to explore therapeutic psychedelics.
• Native American churches ask for peyote to be excluded from decriminalisation.

Medical psychedelics are rapidly disrupting the way we view modern healthcare. Once the darling of the medical community, medical psychedelics are experiencing a renaissance, pushing forward the frontiers of healthcare innovation.

In the wake of the launch of PSYCH: The Psychedelics as Medicine Report, our analysts break down the most important trends and insights set to disrupt the psychedelics industry.

READ NOW

Our international team of researchers, data analysts and industry-leading business experts are on hand to deliver bespoke solutions across the international cannabis market.

If you would like to speak to a member of our team to access strategic consultation for your business, click the button below.

CONTACT OUR TEAM: Info@prohibitionpartners.com